Hugel

2 marketed · 2 in Phase 3

Quick facts

Marketed products

Botulinum toxin type A injection · Neurology; Aesthetics; Dermatology
Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.
Botulinum Toxin Type A Injection [Botox]

Phase 3 pipeline

Botulinum Toxin Type A Injection [HG102] · Neurology; Aesthetics; Pain Management
Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.
Hugeltox · Other

Phase 1 pipeline

Botulinum toxin type A injection [HG-102]

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: